Search Results - "Kamholz, John"

Refine Results
  1. 1

    Post-COVID-19 Fatigue: Potential Contributing Factors by Rudroff, Thorsten, Fietsam, Alexandra C, Deters, Justin R, Bryant, Andrew D, Kamholz, John

    Published in Brain sciences (19-12-2020)
    “…Much of the spotlight for coronavirus disease 2019 (COVID-19) is on the acute symptoms and recovery. However, many recovered patients face persistent physical,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Transcranial Direct Current Stimulation (tDCS) to Improve Gait in Multiple Sclerosis: A Timing Window Comparison by Workman, Craig D, Kamholz, John, Rudroff, Thorsten

    Published in Frontiers in human neuroscience (28-11-2019)
    “…Unilateral weakness of the lower limb is a hallmark of multiple sclerosis (MS) and a significant contributor to the progressive worsening of walking ability…”
    Get full text
    Journal Article
  4. 4

    Statin use and delayed onset of Huntington's disease by Schultz, Jordan L., Nopoulos, Peg C., Killoran, Annie, Kamholz, John A.

    Published in Movement disorders (01-02-2019)
    “…ABSTRACT Background There is evidence to suggest that 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase inhibitors (statins) may be beneficial in Huntington's…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Evaluating depression and suicidality in tetrabenazine users with Huntington disease by Schultz, Jordan L, Killoran, Annie, Nopoulos, Peg C, Chabal, Chloe C, Moser, David J, Kamholz, John A

    Published in Neurology (17-07-2018)
    “…OBJECTIVETo determine whether tetrabenazine (TBZ) use is associated with an increased incidence of depression and/or suicidal ideation. METHODSIn this…”
    Get full text
    Journal Article
  7. 7

    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness by Yadav, Meeta, Ali, Soham, Shrode, Rachel L, Shahi, Shailesh K, Jensen, Samantha N, Hoang, Jemmie, Cassidy, Samuel, Olalde, Heena, Guseva, Natalya, Paullus, Mishelle, Cherwin, Catherine, Wang, Kai, Cho, Tracey, Kamholz, John, Mangalam, Ashutosh K

    Published in PloS one (26-04-2022)
    “…Trillions of microbes such as bacteria, fungi, and viruses exist in the healthy human gut microbiome. Although gut bacterial dysbiosis has been extensively…”
    Get full text
    Journal Article
  8. 8

    Autonomic dysregulation as an early pathologic feature of Huntington Disease by Schultz, Jordan L., Harshman, Lyndsay A., Kamholz, John A., Nopoulos, Peg C.

    Published in Autonomic neuroscience (01-03-2021)
    “…Autonomic nervous system (ANS) dysfunction has been described in adults with motor-manifest Huntington's Disease (HD) or those who are near their predicted…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The Tolerability and Efficacy of 4 mA Transcranial Direct Current Stimulation on Leg Muscle Fatigability by Workman, Craig D, Kamholz, John, Rudroff, Thorsten

    Published in Brain sciences (23-12-2019)
    “…Transcranial direct current stimulation (tDCS) modulates cortical excitability and affects a variety of outcomes. tDCS at intensities ≤2 mA is well-tolerated,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database by Schultz, Jordan L, Kamholz, John A, Moser, David J, Feely, Shawna M.E, Paulsen, Jane S, Nopoulos, Peg C

    Published in Neurology (28-02-2017)
    “…OBJECTIVE:To investigate the relationship between substances of abuse and age at motor onset (AMO) in patients with Huntington disease (HD) in a large and…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice by Patzkó, Ágnes, Bai, Yunhong, Saporta, Mario A., Katona, István, Wu, XingYao, Vizzuso, Domenica, Feltri, M. Laura, Wang, Suola, Dillon, Lisa M., Kamholz, John, Kirschner, Daniel, Sarkar, Fazlul H., Wrabetz, Lawrence, Shy, Michael E.

    Published in Brain (London, England : 1878) (01-12-2012)
    “…Charcot–Marie–Tooth disease type 1B is caused by mutations in myelin protein zero. R98C mice, an authentic model of early onset Charcot–Marie–Tooth disease…”
    Get full text
    Journal Article
  17. 17

    The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series by Trepanier, Angela M., Aguilar, Sienna, Kamholz, John, Laukka, Jeremy J.

    Published in Clinical case reports (01-09-2023)
    “…Key Clinical Message This study aimed to characterize the clinical features, developmental milestones, and the natural history of Pelizaeus–Merzbacher disease…”
    Get full text
    Journal Article
  18. 18

    Spinal Cord Infarction Presenting as a Hemicord Syndrome: Report of 2 Cases by Sharma, Kanika, Kamholz, John A., Leira, Enrique C.

    “…Infarction of the spinal cord is a rare entity in clinical practice. Limited literature exists on spinal cord stroke treatment, and the management is often…”
    Get full text
    Journal Article
  19. 19

    Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll‐HD Database by Schultz, Jordan L., Kamholz, John A., Nopoulos, Peg C., Killoran, Annie

    “…ABSTRACT Introduction Huntington's chorea (HC) is commonly managed with neuroleptic medications, though there is little evidence to support their use. This…”
    Get full text
    Journal Article
  20. 20

    Neuroradiologic correlates of clinical disability and progression in the X-Linked leukodystrophy Pelizaeus–Merzbacher disease by Laukka, Jeremy J, Stanley, Jeffrey A, Garbern, James Y, Trepanier, Angela, Hobson, Grace, Lafleur, Tori, Gow, Alexander, Kamholz, John

    Published in Journal of the neurological sciences (15-12-2013)
    “…Abstract Objective To determine whether quantitative measure of magnetic resonance imaging data from patients with the inherited leukodystrophy,…”
    Get full text
    Journal Article